Loading…
Combined hydroxypropyl-β-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir
The aim of this study was to prepare and characterize an hydroxypropyl-β-cyclodextrin–saquinavir inclusion complex with the purpose of incorporating this complex into poly(alkylcyanoacrylate) nanoparticles in order to increase the drug loading. Hydroxypropyl-β-cyclodextrin–saquinavir complex was cha...
Saved in:
Published in: | International journal of pharmaceutics 2001-05, Vol.218 (1), p.113-124 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c389t-d20ac4d8b158ec33c968448bb4fce7fdc7ea33746638d01ff75cfb143db7e8943 |
---|---|
cites | cdi_FETCH-LOGICAL-c389t-d20ac4d8b158ec33c968448bb4fce7fdc7ea33746638d01ff75cfb143db7e8943 |
container_end_page | 124 |
container_issue | 1 |
container_start_page | 113 |
container_title | International journal of pharmaceutics |
container_volume | 218 |
creator | Boudad, H Legrand, P Lebas, G Cheron, M Duchêne, D Ponchel, G |
description | The aim of this study was to prepare and characterize an hydroxypropyl-β-cyclodextrin–saquinavir inclusion complex with the purpose of incorporating this complex into poly(alkylcyanoacrylate) nanoparticles in order to increase the drug loading. Hydroxypropyl-β-cyclodextrin–saquinavir complex was characterized by thermal (differential scanning calorimetry), crystallographic (X-ray diffractography) and spectroscopic methods (circular dichroism, H
1-NMR). Nanoparticles were prepared by polymerization of alkylcyanoacrylate monomers (isobutyl- and isohexylcyanoacrylate) in a water solution of the complex and further characterized. The apparent solubility of saquinavir was increased 400-fold at pH 7.0 in presence of hydroxypropyl-β-cyclodextrin owing to the formation of a drug–cyclodextrin complex as demonstrated mainly by
1H NMR and confirmed by other techniques. Saquinavir-loaded nanoparticles could be easily prepared in the presence of a drug–cyclodextrin complex. It was found that large amounts of cyclodextrins remained associated with the particles, resulting in a 20-fold increase in saquinavir loading compared to nanoparticles prepared in the absence of cyclodextrins. This study has shown that the loading in saquinavir of poly(alkylcyanoacrylate) nanospheres could be dramatically improved by simultaneously increasing the apparent solubility of the drug in the preparation medium and the amount of cyclodextrin associated with the particles, making these nanospheres a promising system for oral application. |
doi_str_mv | 10.1016/S0378-5173(01)00622-6 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70808046</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517301006226</els_id><sourcerecordid>70808046</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-d20ac4d8b158ec33c968448bb4fce7fdc7ea33746638d01ff75cfb143db7e8943</originalsourceid><addsrcrecordid>eNqFkM1u1DAQgC0EotvCI4AiIaH2ELDXSew9VWhVfqRKHICzNRmPhcGxUztbNTeeiQfhmch2V-WI5jAa6Zu_j7EXgr8RXHRvv3CpdN0KJc-5uOC8W6_r7hFbCa1kLRvVPWarB-SEnZbyg-8pIZ-yEyGkVKJtV-zXNg29j2Sr77PN6W4ecxrnUP_5XeOMIVm6m7KPFURbjSnM5xB-zgFniAkwzwEmuqjiUo2QJ4-BSuXjRNEuE13KVcoQKrCDj75MGSafYpVcVeBm5yPc-vyMPXEQCj0_5jP27f3V1-3H-vrzh0_bd9c1Sr2ZarvmgI3VvWg1oZS46XTT6L5vHJJyFhXB8lPTdVJbLpxTLbpeNNL2ivSmkWfs9WHu8uDNjspkBl-QQoBIaVeM4nqJplvA9gBiTqVkcmbMfoA8G8HNXr25V2_2Xg0X5l692fe9PC7Y9QPZf11H1wvw6ghAQQguQ0RfHriNUmq9WajLA0WLjFtP2RT0FJGsz4STscn_55C_LgKlEA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70808046</pqid></control><display><type>article</type><title>Combined hydroxypropyl-β-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir</title><source>Elsevier</source><creator>Boudad, H ; Legrand, P ; Lebas, G ; Cheron, M ; Duchêne, D ; Ponchel, G</creator><creatorcontrib>Boudad, H ; Legrand, P ; Lebas, G ; Cheron, M ; Duchêne, D ; Ponchel, G</creatorcontrib><description>The aim of this study was to prepare and characterize an hydroxypropyl-β-cyclodextrin–saquinavir inclusion complex with the purpose of incorporating this complex into poly(alkylcyanoacrylate) nanoparticles in order to increase the drug loading. Hydroxypropyl-β-cyclodextrin–saquinavir complex was characterized by thermal (differential scanning calorimetry), crystallographic (X-ray diffractography) and spectroscopic methods (circular dichroism, H
1-NMR). Nanoparticles were prepared by polymerization of alkylcyanoacrylate monomers (isobutyl- and isohexylcyanoacrylate) in a water solution of the complex and further characterized. The apparent solubility of saquinavir was increased 400-fold at pH 7.0 in presence of hydroxypropyl-β-cyclodextrin owing to the formation of a drug–cyclodextrin complex as demonstrated mainly by
1H NMR and confirmed by other techniques. Saquinavir-loaded nanoparticles could be easily prepared in the presence of a drug–cyclodextrin complex. It was found that large amounts of cyclodextrins remained associated with the particles, resulting in a 20-fold increase in saquinavir loading compared to nanoparticles prepared in the absence of cyclodextrins. This study has shown that the loading in saquinavir of poly(alkylcyanoacrylate) nanospheres could be dramatically improved by simultaneously increasing the apparent solubility of the drug in the preparation medium and the amount of cyclodextrin associated with the particles, making these nanospheres a promising system for oral application.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/S0378-5173(01)00622-6</identifier><identifier>PMID: 11337155</identifier><identifier>CODEN: IJPHDE</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>2-Hydroxypropyl-beta-cyclodextrin ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; beta-Cyclodextrins ; Biological and medical sciences ; Calorimetry, Differential Scanning ; Chemistry, Pharmaceutical ; Circular Dichroism ; Cyanoacrylates - chemistry ; Cyclodextrins - administration & dosage ; Cyclodextrins - chemistry ; General pharmacology ; HIV Protease Inhibitors - administration & dosage ; HIV Protease Inhibitors - chemistry ; Hydroxypropyl-β-cyclodextrin ; Inclusion complex ; Magnetic Resonance Spectroscopy ; Medical sciences ; Molecular Structure ; Nanoparticles ; Oral administration ; Particle Size ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Polymers - chemistry ; Saquinavir ; Saquinavir - administration & dosage ; Saquinavir - chemistry ; Solubility ; X-Ray Diffraction</subject><ispartof>International journal of pharmaceutics, 2001-05, Vol.218 (1), p.113-124</ispartof><rights>2001 Elsevier Science B.V.</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-d20ac4d8b158ec33c968448bb4fce7fdc7ea33746638d01ff75cfb143db7e8943</citedby><cites>FETCH-LOGICAL-c389t-d20ac4d8b158ec33c968448bb4fce7fdc7ea33746638d01ff75cfb143db7e8943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=977729$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11337155$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boudad, H</creatorcontrib><creatorcontrib>Legrand, P</creatorcontrib><creatorcontrib>Lebas, G</creatorcontrib><creatorcontrib>Cheron, M</creatorcontrib><creatorcontrib>Duchêne, D</creatorcontrib><creatorcontrib>Ponchel, G</creatorcontrib><title>Combined hydroxypropyl-β-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>The aim of this study was to prepare and characterize an hydroxypropyl-β-cyclodextrin–saquinavir inclusion complex with the purpose of incorporating this complex into poly(alkylcyanoacrylate) nanoparticles in order to increase the drug loading. Hydroxypropyl-β-cyclodextrin–saquinavir complex was characterized by thermal (differential scanning calorimetry), crystallographic (X-ray diffractography) and spectroscopic methods (circular dichroism, H
1-NMR). Nanoparticles were prepared by polymerization of alkylcyanoacrylate monomers (isobutyl- and isohexylcyanoacrylate) in a water solution of the complex and further characterized. The apparent solubility of saquinavir was increased 400-fold at pH 7.0 in presence of hydroxypropyl-β-cyclodextrin owing to the formation of a drug–cyclodextrin complex as demonstrated mainly by
1H NMR and confirmed by other techniques. Saquinavir-loaded nanoparticles could be easily prepared in the presence of a drug–cyclodextrin complex. It was found that large amounts of cyclodextrins remained associated with the particles, resulting in a 20-fold increase in saquinavir loading compared to nanoparticles prepared in the absence of cyclodextrins. This study has shown that the loading in saquinavir of poly(alkylcyanoacrylate) nanospheres could be dramatically improved by simultaneously increasing the apparent solubility of the drug in the preparation medium and the amount of cyclodextrin associated with the particles, making these nanospheres a promising system for oral application.</description><subject>2-Hydroxypropyl-beta-cyclodextrin</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>beta-Cyclodextrins</subject><subject>Biological and medical sciences</subject><subject>Calorimetry, Differential Scanning</subject><subject>Chemistry, Pharmaceutical</subject><subject>Circular Dichroism</subject><subject>Cyanoacrylates - chemistry</subject><subject>Cyclodextrins - administration & dosage</subject><subject>Cyclodextrins - chemistry</subject><subject>General pharmacology</subject><subject>HIV Protease Inhibitors - administration & dosage</subject><subject>HIV Protease Inhibitors - chemistry</subject><subject>Hydroxypropyl-β-cyclodextrin</subject><subject>Inclusion complex</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Medical sciences</subject><subject>Molecular Structure</subject><subject>Nanoparticles</subject><subject>Oral administration</subject><subject>Particle Size</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Polymers - chemistry</subject><subject>Saquinavir</subject><subject>Saquinavir - administration & dosage</subject><subject>Saquinavir - chemistry</subject><subject>Solubility</subject><subject>X-Ray Diffraction</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqFkM1u1DAQgC0EotvCI4AiIaH2ELDXSew9VWhVfqRKHICzNRmPhcGxUztbNTeeiQfhmch2V-WI5jAa6Zu_j7EXgr8RXHRvv3CpdN0KJc-5uOC8W6_r7hFbCa1kLRvVPWarB-SEnZbyg-8pIZ-yEyGkVKJtV-zXNg29j2Sr77PN6W4ecxrnUP_5XeOMIVm6m7KPFURbjSnM5xB-zgFniAkwzwEmuqjiUo2QJ4-BSuXjRNEuE13KVcoQKrCDj75MGSafYpVcVeBm5yPc-vyMPXEQCj0_5jP27f3V1-3H-vrzh0_bd9c1Sr2ZarvmgI3VvWg1oZS46XTT6L5vHJJyFhXB8lPTdVJbLpxTLbpeNNL2ivSmkWfs9WHu8uDNjspkBl-QQoBIaVeM4nqJplvA9gBiTqVkcmbMfoA8G8HNXr25V2_2Xg0X5l692fe9PC7Y9QPZf11H1wvw6ghAQQguQ0RfHriNUmq9WajLA0WLjFtP2RT0FJGsz4STscn_55C_LgKlEA</recordid><startdate>20010507</startdate><enddate>20010507</enddate><creator>Boudad, H</creator><creator>Legrand, P</creator><creator>Lebas, G</creator><creator>Cheron, M</creator><creator>Duchêne, D</creator><creator>Ponchel, G</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010507</creationdate><title>Combined hydroxypropyl-β-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir</title><author>Boudad, H ; Legrand, P ; Lebas, G ; Cheron, M ; Duchêne, D ; Ponchel, G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-d20ac4d8b158ec33c968448bb4fce7fdc7ea33746638d01ff75cfb143db7e8943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>2-Hydroxypropyl-beta-cyclodextrin</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>beta-Cyclodextrins</topic><topic>Biological and medical sciences</topic><topic>Calorimetry, Differential Scanning</topic><topic>Chemistry, Pharmaceutical</topic><topic>Circular Dichroism</topic><topic>Cyanoacrylates - chemistry</topic><topic>Cyclodextrins - administration & dosage</topic><topic>Cyclodextrins - chemistry</topic><topic>General pharmacology</topic><topic>HIV Protease Inhibitors - administration & dosage</topic><topic>HIV Protease Inhibitors - chemistry</topic><topic>Hydroxypropyl-β-cyclodextrin</topic><topic>Inclusion complex</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Medical sciences</topic><topic>Molecular Structure</topic><topic>Nanoparticles</topic><topic>Oral administration</topic><topic>Particle Size</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Polymers - chemistry</topic><topic>Saquinavir</topic><topic>Saquinavir - administration & dosage</topic><topic>Saquinavir - chemistry</topic><topic>Solubility</topic><topic>X-Ray Diffraction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boudad, H</creatorcontrib><creatorcontrib>Legrand, P</creatorcontrib><creatorcontrib>Lebas, G</creatorcontrib><creatorcontrib>Cheron, M</creatorcontrib><creatorcontrib>Duchêne, D</creatorcontrib><creatorcontrib>Ponchel, G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boudad, H</au><au>Legrand, P</au><au>Lebas, G</au><au>Cheron, M</au><au>Duchêne, D</au><au>Ponchel, G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combined hydroxypropyl-β-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2001-05-07</date><risdate>2001</risdate><volume>218</volume><issue>1</issue><spage>113</spage><epage>124</epage><pages>113-124</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><coden>IJPHDE</coden><abstract>The aim of this study was to prepare and characterize an hydroxypropyl-β-cyclodextrin–saquinavir inclusion complex with the purpose of incorporating this complex into poly(alkylcyanoacrylate) nanoparticles in order to increase the drug loading. Hydroxypropyl-β-cyclodextrin–saquinavir complex was characterized by thermal (differential scanning calorimetry), crystallographic (X-ray diffractography) and spectroscopic methods (circular dichroism, H
1-NMR). Nanoparticles were prepared by polymerization of alkylcyanoacrylate monomers (isobutyl- and isohexylcyanoacrylate) in a water solution of the complex and further characterized. The apparent solubility of saquinavir was increased 400-fold at pH 7.0 in presence of hydroxypropyl-β-cyclodextrin owing to the formation of a drug–cyclodextrin complex as demonstrated mainly by
1H NMR and confirmed by other techniques. Saquinavir-loaded nanoparticles could be easily prepared in the presence of a drug–cyclodextrin complex. It was found that large amounts of cyclodextrins remained associated with the particles, resulting in a 20-fold increase in saquinavir loading compared to nanoparticles prepared in the absence of cyclodextrins. This study has shown that the loading in saquinavir of poly(alkylcyanoacrylate) nanospheres could be dramatically improved by simultaneously increasing the apparent solubility of the drug in the preparation medium and the amount of cyclodextrin associated with the particles, making these nanospheres a promising system for oral application.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>11337155</pmid><doi>10.1016/S0378-5173(01)00622-6</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0378-5173 |
ispartof | International journal of pharmaceutics, 2001-05, Vol.218 (1), p.113-124 |
issn | 0378-5173 1873-3476 |
language | eng |
recordid | cdi_proquest_miscellaneous_70808046 |
source | Elsevier |
subjects | 2-Hydroxypropyl-beta-cyclodextrin Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents beta-Cyclodextrins Biological and medical sciences Calorimetry, Differential Scanning Chemistry, Pharmaceutical Circular Dichroism Cyanoacrylates - chemistry Cyclodextrins - administration & dosage Cyclodextrins - chemistry General pharmacology HIV Protease Inhibitors - administration & dosage HIV Protease Inhibitors - chemistry Hydroxypropyl-β-cyclodextrin Inclusion complex Magnetic Resonance Spectroscopy Medical sciences Molecular Structure Nanoparticles Oral administration Particle Size Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Polymers - chemistry Saquinavir Saquinavir - administration & dosage Saquinavir - chemistry Solubility X-Ray Diffraction |
title | Combined hydroxypropyl-β-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T05%3A30%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combined%20hydroxypropyl-%CE%B2-cyclodextrin%20and%20poly(alkylcyanoacrylate)%20nanoparticles%20intended%20for%20oral%20administration%20of%20saquinavir&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Boudad,%20H&rft.date=2001-05-07&rft.volume=218&rft.issue=1&rft.spage=113&rft.epage=124&rft.pages=113-124&rft.issn=0378-5173&rft.eissn=1873-3476&rft.coden=IJPHDE&rft_id=info:doi/10.1016/S0378-5173(01)00622-6&rft_dat=%3Cproquest_cross%3E70808046%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c389t-d20ac4d8b158ec33c968448bb4fce7fdc7ea33746638d01ff75cfb143db7e8943%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70808046&rft_id=info:pmid/11337155&rfr_iscdi=true |